Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2026-03-11 @ 3:41 PM
Study NCT ID:
NCT05850234
Status:
RECRUITING
Last Update Posted:
2025-08-06
First Post:
2023-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma
Sponsor:
AstraZeneca
Organization: